Alicia Alonso de la Vega
192 posts
@Aliciaadv
MSCA Postdoc @TheCrick in @JulianDownward 🌸 Interested in mouse models, lung cancer and tumor immunology 🐭🫁💉
Dr. @molina_arcas highlights preclinical models of oncogenic #KRAS and tumor immunity at the @IASLC #HTTR24 meeting, explaining why some models are representative and some are not. KRAS inhibition increases immune inflammation - in specific models…
How can we extend responses to KRASG12C drugs? Out now in @NatureComms, combining Revolution Medicines’ RAS(ON) G12C-selective inhibitor with a SHP2 inhibitor and immune checkpoint blockade to study their effects on KRAS-mutant lung tumours of varying immunogenicities.
Osmotic Stress Influences Microtubule Drug Response Via WNK1 Kinase Signaling biorxiv.org/cgi/content/sh… #biorxiv_cancer
Next, we heard from @brooke_pereira_ all the way from @GarvanInstitute and @sarahlaing18 from the Murphy group here at @CRUK_SI @UofGMVLS #BICC2024
We are looking for a post-doc with a background in immunology to work on the impact of RAS oncogenic signaling on the interaction of lung cancers with the immune system. Fully funded four year position at Francis Crick Institute in London. #Crick crick.wd3.myworkdayjobs.com/External/job/L…
